Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome
- 12 October 2011
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 21 (4) , 438-440
Abstract
Diffuse alveolar hemorrhage (DAH) is a rare manifestation of primary antiphospholipid antibody syndrome (APS). We describe a patient with primary APS and refractory recurrent episodes of DAH. The patient was admitted 15 times due to recurrent episodes of DAH in a period of 18 months. Multiple immunosuppressive drugs did not improve his condition. Two years after his presentation, he was treated with rituximab (two doses of 1 g, 2 weeks apart). Six months later, the attacks of DAH have gradually disappeared. In a follow-up of more than 2 years after he received rituximab, the patient has had no further admissions due to DAH. Levels of antiphospholipid antibodies were measured during follow-up of 4 years. Anti-β2 glycoprotein IgG titer decreased to normal 6 months after therapy but anticardiolipin (aCL) antibody titer increased. We conclude that rituximab caused a dramatic clinical response in this patient. Anti-β2 glycoprotein IgG correlated better with the clinical response in this patient than aCL.Keywords
This publication has 7 references indexed in Scilit:
- Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhageLupus, 2011
- Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literatureLupus, 2008
- Antiphospholipid Antibodies as a Cause of Pulmonary Capillaritis and Diffuse Alveolar Hemorrhage: A Case Series and Literature ReviewSeminars in Arthritis and Rheumatism, 2005
- Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case reportAnnals of Hematology, 2005
- Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndromeRheumatology, 2004
- The lung in the antiphospholipid syndromeAnnals of the Rheumatic Diseases, 2002
- Recurrent Alveolar Hemorrhage and Pulmonary Capillaritis in the "Primary" Antiphospholipid SyndromeJCR: Journal of Clinical Rheumatology, 2001